American Renal Associates Holdings Inc (ARA) Shares Bought by Van Berkom & Associates Inc.

Van Berkom & Associates Inc. increased its holdings in American Renal Associates Holdings Inc (NYSE:ARA) by 490.5% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,191,863 shares of the company’s stock after buying an additional 1,820,649 shares during the period. Van Berkom & Associates Inc. owned about 7.01% of American Renal Associates worth $32,812,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Schwab Charles Investment Management Inc. boosted its holdings in shares of American Renal Associates by 0.7% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 39,132 shares of the company’s stock valued at $726,000 after buying an additional 285 shares during the period. Rhumbline Advisers lifted its stake in shares of American Renal Associates by 2.7% in the 2nd quarter. Rhumbline Advisers now owns 13,383 shares of the company’s stock worth $248,000 after acquiring an additional 354 shares during the period. Alliancebernstein L.P. lifted its stake in shares of American Renal Associates by 3.0% in the 2nd quarter. Alliancebernstein L.P. now owns 13,900 shares of the company’s stock worth $258,000 after acquiring an additional 400 shares during the period. The Manufacturers Life Insurance Company lifted its stake in shares of American Renal Associates by 19.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 8,778 shares of the company’s stock worth $162,000 after acquiring an additional 1,443 shares during the period. Finally, Teachers Advisors LLC lifted its stake in shares of American Renal Associates by 8.8% in the 2nd quarter. Teachers Advisors LLC now owns 17,910 shares of the company’s stock worth $332,000 after acquiring an additional 1,444 shares during the period. 93.27% of the stock is owned by institutional investors and hedge funds.

A number of research firms recently commented on ARA. Zacks Investment Research downgraded shares of American Renal Associates from a “buy” rating to a “hold” rating in a report on Friday, November 17th. SunTrust Banks set a $18.00 price target on shares of American Renal Associates and gave the company a “buy” rating in a report on Sunday, October 15th. Finally, Leerink Swann restated an “outperform” rating and set a $17.00 price target (down previously from $22.00) on shares of American Renal Associates in a report on Tuesday, November 21st. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. American Renal Associates currently has an average rating of “Buy” and an average target price of $17.75.

Shares of American Renal Associates Holdings Inc (ARA) opened at $14.18 on Wednesday. American Renal Associates Holdings Inc has a 1-year low of $9.91 and a 1-year high of $24.82. The company has a current ratio of 1.16, a quick ratio of 1.13 and a debt-to-equity ratio of 3.57. The stock has a market cap of $442.97, a P/E ratio of 21.01, a PEG ratio of 1.24 and a beta of 4.29.

American Renal Associates (NYSE:ARA) last released its quarterly earnings results on Tuesday, November 14th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.16 by $0.03. American Renal Associates had a negative net margin of 2.15% and a positive return on equity of 15.80%. The business had revenue of $187.71 million for the quarter, compared to analyst estimates of $194.60 million. During the same quarter in the previous year, the business earned $0.28 earnings per share. The firm’s revenue was down 2.7% compared to the same quarter last year. analysts forecast that American Renal Associates Holdings Inc will post 0.57 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “American Renal Associates Holdings Inc (ARA) Shares Bought by Van Berkom & Associates Inc.” was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://ledgergazette.com/2017/12/06/van-berkom-associates-inc-has-32-81-million-position-in-american-renal-associates-holdings-inc-ara.html.

American Renal Associates Company Profile

American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.

Institutional Ownership by Quarter for American Renal Associates (NYSE:ARA)

Receive News & Ratings for American Renal Associates Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply